You have 9 free searches left this month | for more free features.

City

Nantong (1)

Shanghai (1)

Condition

Acute Gout (1)

Chronic Pain (1)

Pharmacological Action (1)

Overall Status

Recruiting (2)

Completed (1)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Affiliated Hospital of Nantong University (1)

Federal State Budgetary Scientific Institution, Scientific Research Institute of Rheumatology (1)

GeneScience Pharmaceuticals Co., Ltd. (1)

Collaborator

Institute of Biomedical Chemistry, Russia (1)

The League of Clinical Research, Russia (1)

Intervention

diprospan (3)

genakumab (1)

placebo for diprospan (1)

placebo for genakumab (1)

ropivacaine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational [Patient Registry] (1)

diprospan

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Gout Trial in Shanghai (genakumab, for Diprospan, for genakumab)

Recruiting

Acute Gout

genakumab
+3 more

Shanghai, Shanghai, China

Fudan University Affiliated Huashan Hospital

Aug 6, 2023

Chronic Pain Trial in Nantong (Diprospan, Ropivacaine)

Recruiting

Chronic Pain

Diprospan
Ropivacaine

Nantong, Jiangsu, China

Affiliated Hospital of Nantong University

Mar 1, 2022

Pharmacological Action Trial (Diprospan)

Completed

Pharmacological Action

Diprospan

(no location specified)

Apr 13, 2017